Evidence map›Paper›PMID 25480561›Full record

ArticleJournal of immunology (Baltimore, Md. : 1950)2015

Natural anti-intestinal goblet cell autoantibody production from marginal zone B cells.

Daiju Ichikawa, Masanao Asano, Susan A Shinton, Joni Brill-Dashoff, Anthony M Formica, Anna Velcich, Richard R Hardy, Kyoko Hayakawa

Open access · bronzeAbstract read
In one paragraph

Article in Journal of immunology (Baltimore, Md. : 1950), 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 20 papers.

0numbers the graph read from it
0cells of the map it votes in
20citing papers in PubMed
2.9field-weighted citation impact, top 9% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

20 citing papers in PubMed, 26 citations in OpenAlex.

  1. Trial
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Review
  10. Innate B Cells: the Archetype of Protective Immune Cells.Clinical reviews in allergy & immunology · 2020
    Review
  11. Secreted IgM: New tricks for an old molecule.Journal of leukocyte biology · 2019
    Review
  12. Article
  13. Article
  14. Article
  15. Defining Natural Antibodies.Frontiers in immunology · 2017
    Article
  16. Article
  17. Article
  18. Review
  19. Characteristics of natural antibody-secreting cells.Annals of the New York Academy of Sciences · 2015
    Review
  20. Perspectives on fetal derived CD5+ B1 B cells.European journal of immunology · 2015
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 2 institutions in 2 countries.

Daiju IchikawaFox Chase Cancer Center, Philadelphia, PA 19111; Keio University Faculty of Pharmacy, Tokyo 105-8512, Japan;
Masanao AsanoFox Chase Cancer Center, Philadelphia, PA 19111; Juntendo University School of Medicine, Tokyo 113, Japan; and.
Susan A ShintonFox Chase Cancer Center, Philadelphia, PA 19111;
Joni Brill-DashoffFox Chase Cancer Center, Philadelphia, PA 19111;
Anthony M FormicaFox Chase Cancer Center, Philadelphia, PA 19111;
Anna VelcichAlbert Einstein Cancer Center/Montefiore Medical Center, Bronx, NY 10467.
Richard R HardyFox Chase Cancer Center, Philadelphia, PA 19111;
Kyoko HayakawaFox Chase Cancer Center, Philadelphia, PA 19111; Kyoko.Hayakawa@fccc.edu.
Fox Chase Cancer Center · USAlbert Einstein College of Medicine · US

Funding

LY-1 B CELLS--LINEAGE DETERMINATION/ANTIBODY REPERTOIRER01AI026782 · NIAID · RESEARCH INST OF FOX CHASE CAN CTR · PI HARDY, RICHARD R · 1990 to 2011
$5.5M
Development and Function of Natural Autoreactive B CellsR01AI049335 · NIAID · RESEARCH INST OF FOX CHASE CAN CTR · PI HAYAKAWA, KYOKO · 2002 to 2012
$4.1M
Origin of CD5+ B cell Lymphoma/Leukemia in MiceR01CA129330 · NCI · RESEARCH INST OF FOX CHASE CAN CTR · PI HAYAKAWA, KYOKO · 2009 to 2013
$1.8M
Development and Function of Natural Autoreactive B CellsR21AI049335 · NIAID · INSTITUTE FOR CANCER RESEARCH · PI HAYAKAWA, KYOKO · 2001 to 2001
$461k
Ly-1 B Cells: Developmental Origins and V Gene BiasesR56AI026782 · NIAID · RESEARCH INST OF FOX CHASE CAN CTR · PI HARDY, RICHARD R · 2013 to 2013
$313k
NCI NIH HHS CA129330NCI NIH HHS R01 CA129330NIAID NIH HHS AI026782NIAID NIH HHS AI49335NIAID NIH HHS R01 AI026782NIAID NIH HHS R01 AI049335NIAID NIH HHS R21 AI049335NIAID NIH HHS R56 AI026782
6 · The paper itself

Abstract

Expression of a germline VH3609/D/JH2 IgH in mice results in the generation of B1 B cells with anti-thymocyte/Thy-1 glycoprotein autoreactivity by coexpression of Vk21-5/Jk2 L chain leading to production of serum IgM natural autoantibody. In these same mice, the marginal zone (MZ) B cell subset in spleen shows biased usage of a set of Ig L chains different from B1 B cells, with 30% having an identical Vk19-17/Jk1 L chain rearrangement. This VH3609/Vk19-17 IgM is reactive with intestinal goblet cell granules, binding to the intact large polymatrix form of mucin 2 glycoprotein secreted by goblet cells. Analysis of a μκ B cell AgR (BCR) transgenic (Tg) mouse with this anti-goblet cell/mucin2 autoreactive (AGcA) specificity demonstrates that immature B cells expressing the Tg BCR become MZ B cells in spleen by T cell-independent BCR signaling. These Tg B cells produce AGcA as the predominant serum IgM, but without enteropathy. Without the transgene, AGcA autoreactivity is low but detectable in the serum of BALB/c and C.B17 mice, and this autoantibody is specifically produced by the MZ B cell subset. Thus, our findings reveal that AGcA is a natural autoantibody associated with MZ B cells.

Indexed as

AnimalsAutoantibodiesB-Lymphocyte SubsetsGoblet CellsImmunoglobulin Heavy ChainsImmunoglobulin kappa-ChainsImmunoglobulin MMiceMice, Inbred BALB CMice, TransgenicMucin-2Receptors, Antigen, B-CellSecretory VesiclesSpleenAutoantibodiesImmunoglobulin Heavy ChainsImmunoglobulin kappa-ChainsImmunoglobulin MMuc2 protein, mouseMucin-2Receptors, Antigen, B-Cell

Identifiers

PMID25480561
PMCPMC4282382
OpenAlexW2109631938

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.